SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-062590
Filing Date
2019-11-12
Accepted
2019-11-12 16:01:59
Documents
62
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-17622_110q.htm 10-Q 841824
2 EX-31.1 a19-17622_1ex31d1.htm EX-31.1 11188
3 EX-31.2 a19-17622_1ex31d2.htm EX-31.2 11374
4 EX-32.1 a19-17622_1ex32d1.htm EX-32.1 5628
5 EX-32.2 a19-17622_1ex32d2.htm EX-32.2 5626
  Complete submission text file 0001104659-19-062590.txt   5037483

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cycn-20190930.xml EX-101.INS 1137994
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cycn-20190930.xsd EX-101.SCH 43475
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cycn-20190930_cal.xml EX-101.CAL 45203
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cycn-20190930_def.xml EX-101.DEF 137666
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cycn-20190930_lab.xml EX-101.LAB 428193
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cycn-20190930_pre.xml EX-101.PRE 294597
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 191209192
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences